⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4197117 | 0.90 | — | — | |
| SCHEMBL9309574 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL29280653 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL5842344 | 0.87 | — | — | |
| SCHEMBL4199296 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL29170713 | 0.72 | — | — | |
| SCHEMBL250773 | 0.72 | — | — | |
| SCHEMBL22485671 | 0.71 | — | — | |
| SCHEMBL4714661 | 0.69 | — | — | |
| SCHEMBL5052172 | 0.69 | NFKB1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020045574-A1 | Glycopeptide antibacterial compounds and methods of using same | PRINCETON UNIVERSITY | 2002-04-18 | — | — | US | claimed |
| WO-2001081373-A2 | GLYCOPEPTIDE ANTIBACTERIAL COMPOUNDS AND METHODS OF USING SAME | MERCK & CO., INC. (US) | 2001-11-01 | — | — | WO | claimed |
| CN-108530636-B | Single functionalized branched polyethylene glycol | 厦门赛诺邦格生物科技股份有限公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-108530637-B | Preparation method of single-functionalized branched polyethylene glycol | 厦门赛诺邦格生物科技股份有限公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-108530617-B | Branched polyethylene glycol heterobifunctional derivative, preparation method thereof and two-component bio-related substance conjugate thereof | 厦门赛诺邦格生物科技股份有限公司 | 2020-11-27 | — | — | CN | disclosed |
| EP-3508492-A1 | TIACUMICIN DERIVATIVES AND THEIR USE AS ANTIBIOTICS | Universität Zürich (CH) | 2019-07-10 | — | — | EP | disclosed |
| US-20140030182-A1 | CARBON FILMS PRODUCED FROM IONIC LIQUID CARBON PRECURSORS | UT-BATTELLE, LLC (US) | 2014-01-30 | — | — | US | disclosed |
| CN-102869660-A | Aminothiazolones as estrogen related receptor-alpha modulators | JANSSEN PHARMACEUTICA NV | 2013-01-09 | — | — | CN | disclosed |
| CN-101679241-B | Prolinamide derivatives as NK3 antagonists | HOFFMANN LA ROCHE | 2012-06-27 | — | — | CN | disclosed |
| CN-101679241-A | Prolinamide derivatives as NK3 antagonists | HOFFMANN LA ROCHE | 2010-03-24 | — | — | CN | disclosed |
| US-20090012054-A1 | Cephem Compounds and Use as Antimicrobial Agents | ASTELLAS PHARMA INC. (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1994035-A1 | CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| EP-1925617-A1 | HETEROCYCLIC COMPOUND, AND PRODUCTION PROCESS AND USE THEREOF | ASKA Pharmaceutical Co., Ltd. (JP) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007142986-A2 | AMINOTHIAZOLE DERIVATIVES AND THEIR USES AS ANTIBACTERIAL AGENTS | NOVARTIS AG (CH) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007119511-A1 | CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS | ASTELLAS PHARMA INC. (JP) | 2007-10-25 | — | — | WO | disclosed |